Sean D. Donevan

Statistics

Publications

Citations

2.7K

H-Index

Active since

1988

Affiliations

National Institute of Neurological Disorders and Stroke(Current)

National Institutes of Health

University of Utah

Pfizer (United States)

Queen's University

Sean D. Donevan is an author at National Institute of Neurological Disorders and Stroke specializing in neuroscience, neuropharmacology, and pharmacology.

Publications per year

1988–2015

Publications

GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses

Sean D. Donevan, Michael A. Rogawski · Neuron · 1993 · 359 citations

Medicine, Neuroscience, Pharmacology +15

Intracellular polyamines mediate inward rectification of Ca(2+)-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.

Sean D. Donevan, Michael A. Rogawski · Proceedings of the National Academy of Sciences · 1995 · 233 citations

Life Sciences, Neurobiology, Neuroscience +17

Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons.

Jong M. Rho, Sean D. Donevan, Michael A. Rogawski · The Journal of Physiology · 1996 · 186 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Mechanism of action of the anticonvulsant felbamate: Opposing effects on <i>N</i>‐methyl‐<scp>D</scp>‐aspartate and γ‐aminobutyric acid<sub>A</sub> receptors

Jong M. Rho, Sean D. Donevan, Michael A. Rogawski · Annals of Neurology · 1994 · 185 citations

Medicine, Neuroscience, Pharmacology +17

Acetoacetate, Acetone, and Dibenzylamine (a Contaminant in <scp>l</scp>‐(+)‐β‐Hydroxybutyrate) Exhibit Direct Anticonvulsant Actions in Vivo

Jong M. Rho, Gail D. Anderson, Sean D. Donevan et al. · Epilepsia · 2002 · 156 citations

Medicine, Neuroscience, Pharmacology +12

1–5 of 31